Section 1 Expanding application of Medicaid State programs to monitor antipsychotic medications to all Medicaid beneficiaries
Section 1902(oo) of the Social Security Act (42 U.S.C. 1396a(oo)) is amended—
in paragraph (1)(B)—
in the subparagraph header, by striking “by children”;
by inserting “, and, beginning January 1, 2024, by individuals (regardless of age) enrolled,” after “children enrolled”; and
by striking “for individuals not more than the age of 18 years generally and children in foster care specifically” and inserting “, including for individuals not more than the age of 18 years generally, children in foster care specifically, and, beginning January 1, 2024, individuals over the age of 65, individuals receiving home and community-based services (as defined in section 9817(a)(2) of Public Law 117–2), and individuals residing in institutional care settings, including nursing facilities and intermediate care facilities for individuals with intellectual disabilities”; and
in paragraph (3)—
in subparagraph (A)(ii), by striking “is a resident” and inserting “subject to subparagraph (C), is a resident”; and
by adding at the end the following new subparagraph:
“(C) Application in case of program to monitor antipsychotic medications—Subparagraph (A)(ii) shall not apply to the drug review and utilization requirement described in subparagraph (1)(B) with respect to an individual 18 years of age or older.”